Christine Castillo, DO
Family Medicine · Hamilton, NJNPI 1831276294
Payments from drug & device makers
Across 43 payments — averaging $15.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$156
- AstraZeneca$115
- Pfizer$89
- GSK$34
- Johnson & Johnson$28
- Solventum Corporation$27
- plus $203 from 12 others
What the payments were for
- Food & beverage$652100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 11 | $156 |
| AstraZeneca | 8 | $115 |
| Pfizer | 6 | $89 |
| GSK | 2 | $34 |
| Johnson & Johnson | 2 | $28 |
| Solventum Corporation | 2 | $27 |
| Exact Sciences | 1 | $26 |
| Dynavax Technologies Corporation | 1 | $20 |
| Abbott | 1 | $19 |
| Boehringer Ingelheim | 1 | $19 |
| Idorsia Pharmaceuticals US Inc | 1 | $16 |
| Kls-martin L.p. | 1 | $16 |
| Sanofi-aventis U.S. LLC | 1 | $15 |
| Genentech USA, Inc. | 1 | $15 |
| Amarin Pharma, Inc. | 1 | $15 |
| Merck | 1 | $14 |
| Amgen | 1 | $14 |
| Otsuka America Pharmaceutical, Inc. | 1 | $13 |
How this compares
$652 in reported general payments places this provider in the 55th percentile of 2,084 family medicine providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Amlodipine-ValsartanAmlodipine Besylate/Valsartan | 15 | $2,099 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 51 | $2,088 |
| Atorvastatin Calcium | 155 | $1,875 |
| Metoprolol Succinate | 94 | $1,787 |
| Rosuvastatin Calcium | 112 | $1,585 |
| Levothyroxine Sodium | 131 | $1,362 |
| Valsartan | 33 | $1,328 |
| FenofibrateFenofibrate Nanocrystallized | 13 | $1,046 |
| Amlodipine Besylate | 151 | $1,046 |
| Ezetimibe | 11 | $957 |
| Metformin Hcl ErMetformin Hcl | 38 | $837 |
| Pantoprazole Sodium | 38 | $765 |
| Losartan Potassium | 79 | $743 |
| Lisinopril | 58 | $633 |
| Sertraline Hcl | 48 | $628 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Hamilton
- Howard HassmanClementon$47.1M
- Matthew HongNorth Cape May$15.3M
- Rubaba HussainClark$3.8M
- Gaurang BrahmbhattHoboken$2.6M
- Michael DobrowClifton$2.1M
- Mikhail VarshavskiChatham$1.4M
- Amit BhalodiaCamden$707K
- Jennifer AmicoNew Brunswick$627K
- Janet ColeFar Hills$466K
- Matthew PintoMarlton$239K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.